{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:59:53Z","timestamp":1697425193464},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1007\/s11894-999-0084-5","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T02:46:35Z","timestamp":1180061195000},"page":"30-37","source":"Crossref","is-referenced-by-count":21,"title":["Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis"],"prefix":"10.1007","volume":"1","author":[{"given":"Herbert L.","family":"Bonkovsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge V.","family":"Obando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"84_CR1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-1007220","volume":"16","author":"HL Bonkovsky","year":"1996","unstructured":"Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RR: Iron in Liver diseases other than hemochromatosis Semin Liver Dis 1996, 16:65\u201381.","journal-title":"Semin Liver Dis"},{"issue":"suppl 1","key":"84_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(98)80368-1","volume":"28","author":"A Pietrangelo","year":"1998","unstructured":"Pietrangelo A: Iron, oxidative stress and liver fibrogenesis. J Hepatol (suppl 1) 1998, 28:8\u201313.","journal-title":"J Hepatol"},{"key":"84_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-1007214","volume":"16","author":"RS Britton","year":"1996","unstructured":"Britton RS: Metal induced hepatotoxicity. Semin Liver Dis 1996, 16:3\u201312.","journal-title":"Semin Liver Dis"},{"key":"84_CR4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0016-5085(98)70320-8","volume":"114","author":"DHG Crawford","year":"1998","unstructured":"Crawford DHG, Jazwinska EC, Cullen LM, Powell LW: Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998, 114:1003\u20131008.","journal-title":"Gastroenterology"},{"key":"84_CR5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/bcmd.1997.0148","volume":"23","author":"RL Sham","year":"1997","unstructured":"Sham RL, Ou CY, Cappuccio J, et al.: Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Blood Cells Mol Dis 1997, 23:314\u2013320.","journal-title":"Blood Cells Mol Dis"},{"key":"84_CR6","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/0016-5085(92)90339-Z","volume":"102","author":"AM Bisceglie Di","year":"1992","unstructured":"Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR: Measurements of iron status in patients with chronic hepatitis Gastroenterology 1992, 102:2108\u20132113.","journal-title":"Gastroenterology"},{"key":"84_CR7","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/BF02087705","volume":"39","author":"N Arber","year":"1994","unstructured":"Arber N, Konikoff FM, Moshkowitz M, et al.: Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Dig Dis Sci 1994, 39:2656\u20132659.","journal-title":"Dig Dis Sci"},{"key":"84_CR8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.510250345","volume":"25","author":"HL Bonkovsky","year":"1997","unstructured":"Bonkovsky HL, Banner BF, Rothman AL: Iron and chronic viral hepatitis. Hepatology 1997, 25:759\u2013768.","journal-title":"Hepatology"},{"key":"84_CR9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/0016-5085(95)90209-0","volume":"108","author":"JK Olynyk","year":"1995","unstructured":"Olynyk JK, Reddy KR, Di Bisceglie AM, et al.: Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995 108:1104\u20131109.","journal-title":"Gastroenterology"},{"key":"84_CR10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0168-8278(94)80017-0","volume":"20","author":"DH Thiel Van","year":"1994","unstructured":"Van Thiel DH, Friedlander L, Fagioli S: Response to interferon alfa therapy is influenced by the iron content of the liver. J Hepatol 1994, 20:410\u2013415.","journal-title":"J Hepatol"},{"key":"84_CR11","first-page":"1367","volume":"91","author":"Y Ikura","year":"1996","unstructured":"Ikura Y, Morimoto H, Johmura H: Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol 1996, 91:1367\u20131373.","journal-title":"Am J Gastroenterol"},{"key":"84_CR12","first-page":"232","volume":"8","author":"BF Banner","year":"1995","unstructured":"Banner BF, Barton AL, Cable EE, et al.: A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C. Mod Pathol 1995, 8:232\u2013238.","journal-title":"Mod Pathol"},{"key":"84_CR13","doi-asserted-by":"crossref","first-page":"215A","DOI":"10.1016\/S0168-8278(97)80029-3","volume":"26","author":"H Hayashi","year":"1997","unstructured":"Hayashi H, Wakusawa S, Takikawa T, et al.: Long-term effect o iron removal on chronic hepatitis C [abstract]. Hepatology 1997, 26 (suppl): 215A.","journal-title":"Hepatology"},{"key":"84_CR14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0168-8278(98)80308-5","volume":"28","author":"TL Fong","year":"1998","unstructured":"Fong TL, Han SH, Tsai NC, et al.: A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C. J Hepatol 1998, 28:369\u2013374.","journal-title":"J Hepatol"},{"key":"84_CR15","first-page":"474A","volume":"114","author":"S Barrett","year":"1998","unstructured":"Barrett S, Callagy G, Ryan E, et al.: The C282Y mutation is not a significant cofactor for more severe liver disease in a cohort of Irish hepatitis C patients [abstract]. Gastroenterology 1998, 114:474A.","journal-title":"Gastroenterology"},{"key":"84_CR16","first-page":"410A","volume":"26","author":"SG Gehrke","year":"1997","unstructured":"Gehrke SG, Riedel HD, Fitscher BA, et al.: Prevalence of mutations in the hemochromatosis gene HLA-H in patients with chronic hepatitis C: influence on histologic activity, iron metabolism and response to interferon therapy [abstract]. Hepatology 1997, 26 (suppl): 410A.","journal-title":"Hepatology"},{"key":"84_CR17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.510270148","volume":"27","author":"C Hezode","year":"1998","unstructured":"Hezode C, Cazeneuve C, Coue O, et al.: Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C [letter]. Hepatology 1998, 27:306.","journal-title":"Hepatology"},{"key":"84_CR18","doi-asserted-by":"crossref","first-page":"55A","DOI":"10.1016\/S0168-8278(98)80420-0","volume":"28","author":"ALC Martinelli","year":"1998","unstructured":"Martinelli ALC, Franco RF, Villanova AB: Haemochromatosis Cys282Tyr and His63Asp mutations in hepatitis C virus infection. correlation with ALT and iron serum levels. J Hepatol 1998, 28 (suppl): 55A.","journal-title":"J Hepatol"},{"key":"84_CR19","doi-asserted-by":"crossref","first-page":"144A","DOI":"10.1016\/S0168-8278(98)80767-8","volume":"28","author":"P Ferenci","year":"1998","unstructured":"Ferenci P, Datz C, Kazemi-Sirasi L, et al.: HLA mutations in patient with chronic hepatitis C [abstract]. J Hepatol 1998, 28 (suppl): 144A.","journal-title":"J Hepatol"},{"key":"84_CR20","doi-asserted-by":"crossref","first-page":"146A","DOI":"10.1016\/S0168-8278(98)80772-1","volume":"28","author":"A Vergani","year":"1998","unstructured":"Vergani A, Vigano M, Malosio I, et al.: HFE gene mutations and alcohol intake are main determinants of liver iron overload in male patients with chronic viral hepatitis. J Hepatol 1998, 28 (suppl): 146A.","journal-title":"J Hepatol"},{"key":"84_CR21","doi-asserted-by":"crossref","first-page":"98A","DOI":"10.1016\/S0168-8278(98)80589-8","volume":"28","author":"M Sampietro","year":"1998","unstructured":"Sampietro M, Boldorini R, Corbeta M: Liver iron distribution, histological activity and mutations in the hemochromatosis gene (HFE) in chronic hepatitis C [abstract]. J Hepatol 1998, 28 (suppl): 98A.","journal-title":"J Hepatol"},{"key":"84_CR22","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hep.510270631","volume":"27","author":"BC Smith","year":"1998","unstructured":"Smith BC, Gorve J, Guzail MA: Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998, 27:1695\u20131699.","journal-title":"Hepatology"},{"key":"84_CR23","doi-asserted-by":"crossref","first-page":"145A","DOI":"10.1016\/S0168-8278(98)80769-1","volume":"28","author":"M Sampietro","year":"1998","unstructured":"Sampietro M, Corbetta N, Amato M, et al.: Mutations in the hemochromatosis gene and response to interferon in chronic hepatitis C. J Hepatol 1998, 28 (suppl): 145A.","journal-title":"J Hepatol"},{"key":"84_CR24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.510270237","volume":"27","author":"MJ Moran","year":"1998","unstructured":"Moran MJ, Fontanellas A, Brudieux E, et al.: Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection. Hepatology 1998, 27:584\u2013589.","journal-title":"Hepatology"},{"key":"84_CR25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(85)90287-9","volume":"ii","author":"GH Elder","year":"1985","unstructured":"Elder GH, Urquhart AJ, De Salamanca RE, et al.: Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet 1985, ii:229\u2013233.","journal-title":"Lancet"},{"key":"84_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-1007220","volume":"16","author":"HL Bonkovsky","year":"1996","unstructured":"Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RR: Iron in liver diseases other than hemochromatosis. . Semin Liver Dis 1996, 16:65\u201381.","journal-title":". Semin Liver Dis"},{"key":"84_CR27","first-page":"75","volume":"4","author":"HL Bonkovsky","year":"1998","unstructured":"Bonkovsky HL: Porphyria cutanea tarda and hepatitis C. Viral Hepatitis Rev 1998, 4:75\u201395.","journal-title":"Viral Hepatitis Rev"},{"key":"84_CR28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/hep.1840100319","volume":"10","author":"HL Bonkovsky","year":"1989","unstructured":"Bonkovsky HL: Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells. Hepatology 1989,10:354\u2013364.","journal-title":"Hepatology"},{"key":"84_CR29","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/hep.510270627","volume":"27","author":"HL Bonkovsky","year":"1998","unstructured":"Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, et al.: Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998, 27:1661\u20131669. This description of 70 patients in the United States with PCT showed a high prevalence of the HFE gene mutations as well as other risk factors such as estrogen and alcohol consumption.","journal-title":"Hepatology"},{"key":"84_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(96)09436-6","volume":"349","author":"AG Roberts","year":"1998","unstructured":"Roberts AG, Whatley SD, Morgan RR, et al.: Increased frequency of hemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1998, 349:321\u2013323.","journal-title":"Lancet"},{"key":"84_CR31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0168-8278(98)80313-9","volume":"28","author":"KA Stuart","year":"1998","unstructured":"Stuart KA, Busfield F, Jazwinska EC: The C282Y mutation in the haemochromatosis (HFE) gene and hepatitis C virus infection are independent cofactors in porphyria cutanea tarda in Australian patients. J Hepatol 1998, 28:404\u2013409.","journal-title":"J Hepatol"},{"key":"84_CR32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.510270128","volume":"27","author":"M Sampietro","year":"1998","unstructured":"Sampietro M, Piperno A, Lupica L, et al.: High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998, 27:181\u2013184.","journal-title":"Hepatology"},{"key":"84_CR33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510270142","volume":"27","author":"GH Elder","year":"1998","unstructured":"Elder GH: Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload. Hepatology 1998, 27:289\u2013291.","journal-title":"Hepatology"},{"key":"84_CR34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1440-1746.1997.tb00450.x","volume":"12","author":"J Ludwig","year":"1997","unstructured":"Ludwig J, McGill DB, Lindor KD: Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol 1997, 12:398\u2013403.","journal-title":"J Gastroenterol Hepatol"},{"key":"84_CR35","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","volume":"107","author":"BR Bacon","year":"1994","unstructured":"Bacon BR, Farahvash MJ, Janney CG, et al.: Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994, 107:1103-.","journal-title":"Gastroenterology"},{"key":"84_CR36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0016-5085(98)70482-2","volume":"114","author":"DK George","year":"1998","unstructured":"George DK, Goldwurm S, MacDonald GA, et al.: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998, 114:311\u2013318. This is the first description of NASH in 51 patients showing a high percentage of the C282Y mutation.","journal-title":"Gastroenterology"},{"key":"84_CR37","doi-asserted-by":"crossref","first-page":"1264A","DOI":"10.1016\/S0016-5085(98)85132-9","volume":"114","author":"Q Jawaid","year":"1998","unstructured":"Jawaid Q, LeClair P, Tortorelli K, et al.: Non-alcoholic steatohepatitis (NASH) and hereditary hemochromatosis (HHC) [abstract]. Gastroenterology 1998,114:1264A.","journal-title":"Gastroenterology"},{"key":"84_CR38","first-page":"20","volume":"41","author":"N Milman","year":"1994","unstructured":"Milman N, Graudal N, Hegnhoj J, et al.: Relationships among serum iron status markers, chemical and histochemical liver iron content in 117 patients with alcoholic and nonalcoholic hepatic disease. Hepatogastroenterology 1994, 41:20\u201324.","journal-title":"Hepatogastroenterology"},{"key":"84_CR39","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1172\/JCI118077","volume":"96","author":"H Tsukamoto","year":"1995","unstructured":"Tsukamoto H, Horne W, Kamimura S, et al.: Experimental liver cirrhosis caused by alcohol and iron. J Clin Invest 1995, 96:620\u2013630.","journal-title":"J Clin Invest"},{"key":"84_CR40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM199201093260204","volume":"326","author":"V Gordeuk","year":"1992","unstructured":"Gordeuk V, Mukiibi J, Hasstedt SJ, et al.: Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 1992, 326:95\u2013100.","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"84_CR41","first-page":"275A","volume":"26","author":"J Grove","year":"1997","unstructured":"Grove J, Daly AK, Burt AD: HLA-H mutations and hepatic iron content and risk of advanced liver disease in alcoholics [abstract]. Hepatology 1997, 26 (suppl 1): 275A.","journal-title":"Hepatology"},{"key":"84_CR42","first-page":"1401A","volume":"112","author":"M Thursz","year":"1997","unstructured":"Thursz M, Mantafounis D, Yallop R, et al.: Severe alcoholic liver disease is associated with the haemochromatosis gene mutant [abstract]. Gastroenterology 1997, 112:1401A.","journal-title":"Gastroenterology"},{"key":"84_CR43","first-page":"35A","volume":"59","author":"A Frenzer","year":"1998","unstructured":"Frenzer A, Norton ID, Butler WJ, et al.: Heterozygosity of the hemochromatosis mutation C282Y does not influence the susceptibility to alcohol induced cirrhosis [abstract]. Digestion 1998, 59:35A.","journal-title":"Digestion"},{"key":"84_CR44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0016-5085(19)33299-8","volume":"63","author":"JA Baker","year":"1972","unstructured":"Baker JA, Cohen M: Development of hemosiderosis after sidetoside portacaval shunting. Gastroenterology 1972, 63:491\u2013494.","journal-title":"Gastroenterology"},{"key":"84_CR45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/00365521.1966.11800630","volume":"1","author":"M Brodanova","year":"1966","unstructured":"Brodanova M, Hoenig V: Iron metabolism in patients with porta-caval shunts. Scand J Gastroenterol 1966, 1:167\u2013172.","journal-title":"Scand J Gastroenterol"},{"key":"84_CR46","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0046-8177(81)80337-1","volume":"12","author":"CM Lombard","year":"1989","unstructured":"Lombard CM, Strauchen JA: Postshunt hemosiderosis with cardiomyopathy. Hum Pathol 1989, 12:1149\u20131151.","journal-title":"Hum Pathol"},{"key":"84_CR47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.1840190117","volume":"19","author":"PC Adams","year":"1994","unstructured":"Adams PC, Bradley C, Frei JV: Hepatic iron and zinc accumulation after portacaval shunting in nonalcoholic cirrhosis. Hepatology 1994, 19:101\u2013105.","journal-title":"Hepatology"},{"key":"84_CR48","first-page":"334","volume":"78","author":"RC Doberneck","year":"1975","unstructured":"Doberneck RC, Fischer R, Smith D: Gastrojejunostomy inhibits postshunt siderosis. Surgery 1975, 78:334\u2013338.","journal-title":"Surgery"},{"key":"84_CR49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-1007222","volume":"16","author":"EM Brunt","year":"1996","unstructured":"Brunt EM, Tavill AS, Bacon BR: A 49 year old man with alpha1-antitrypsin deficiency and abnormal iron study results. Semin Liver Dis 1996, 16:65\u201381.","journal-title":"Semin Liver Dis"},{"key":"84_CR50","doi-asserted-by":"crossref","first-page":"145 148","DOI":"10.1002\/hep.1840160124","volume":"16","author":"M Rabinovitz","year":"1992","unstructured":"Rabinovitz M, Gavaler JS, Kelly RH, Van Thiel DH: Association between heterozygous alpha1-antitrypsin deficiency and genetic hemochromatosis Hepatology 1992, 16:145 148.","journal-title":"Hepatology"},{"key":"84_CR51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840180338","volume":"18","author":"R Kaserbacher","year":"1993","unstructured":"Kaserbacher R, Propst T, Propst A, et al.: Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis Hepatology 1993, 18:707\u2013708.","journal-title":"Hepatology"},{"key":"84_CR52","first-page":"1161","volume":"24","author":"S Fargion","year":"1996","unstructured":"Fargion S, Bissolo F, Fracanzani AL: No association between genetic hemochromatosis and alpha 1-antitrypsin deficiency. Hepatology 1996, 24:1161\u20131164.","journal-title":"Hepatology"},{"key":"84_CR53","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1572-0241.1998.00478.x","volume":"93","author":"BF Banner","year":"1998","unstructured":"Banner BF, Karamitsios N, Smith L, Bonkovsky HL: Enhanced phenotypic expression of alpha-1 antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C. Am J Gastroenterol 1998, 93:1541\u20131545.","journal-title":"Am J Gastroenterol"},{"key":"84_CR54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0168-8278(98)80011-1","volume":"29","author":"SJ Cotler","year":"1998","unstructured":"Cotler SJ, Bronner MP, Press RD, Kowdley KV: End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998, 29:257\u2013262.","journal-title":"J Hepatol"},{"key":"84_CR55","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/gast.1997.v112.pm9041250","volume":"112","author":"J Ludwig","year":"1997","unstructured":"Ludwig J, Hashimoto E, Porayko MK: Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997, 112:882\u2013888.","journal-title":"Gastroenterology"},{"key":"84_CR56","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ijc.2910430304","volume":"43","author":"HW Hann","year":"1989","unstructured":"Hann HW, Kim CY, London WT, et al.: Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Int J Cancer 1989, 43:376\u2013379.","journal-title":"Int J Cancer"},{"key":"84_CR57","doi-asserted-by":"crossref","unstructured":"Deugnier Y, Turlin B, Loreal O, et al.: Iron and neoplasia. J Hepatol 1998:21\u201325.","DOI":"10.1016\/S0168-8278(98)80371-1"},{"key":"84_CR58","doi-asserted-by":"crossref","first-page":"93A","DOI":"10.1016\/S0168-8278(98)80568-0","volume":"28","author":"S Fargion","year":"1998","unstructured":"Fargion S, Mattioli M, Sampietro M, et al.: Iron as risk factor for hepatocellular carcinoma [abstract]. J Hepatol 1998, 28 (suppl): 93A.","journal-title":"J Hepatol"},{"key":"84_CR59","first-page":"159A","volume":"26","author":"S Fargion","year":"1997","unstructured":"Fargion S, Mattioli M, Sampietro M, et al.: High prevalence of undiagnosed genetic hemochromatosis in Italian patients submitted to orthotopic liver transplant [abstract]. Hepatology 1997, 26:159A.","journal-title":"Hepatology"},{"key":"84_CR60","first-page":"521A","volume":"59","author":"P Constantini","year":"1998","unstructured":"Constantini P, Kahler CH, Graziadei I, et al.: The influence of His63Asp HLA-H on prognosis and progression of chronic liver disease [abstract]. Digestion 1998, 59(suppl):521A.","journal-title":"Digestion"},{"key":"84_CR61","doi-asserted-by":"crossref","first-page":"158A","DOI":"10.1016\/S0168-8278(97)80022-0","volume":"26","author":"DJ Brandhagen","year":"1997","unstructured":"Brandhagen DJ, Porayko MK, Moyer TP, et al.: Genetic testing for hemochromatosis in liver transplantation recipients with hepatic explant hemosiderosis [abstract]. Hepatology 1997, 26:158A.","journal-title":"Hepatology"},{"key":"84_CR62","doi-asserted-by":"crossref","first-page":"158A","DOI":"10.1016\/S0168-8278(97)80022-0","volume":"26","author":"JT Minguillan","year":"1997","unstructured":"Minguillan JT, Lee RG, Britton R, et al.: Genetic markers for hemochromatosis in patients with cirrhosis and iron overload [abstract]. Hepatology 1997, 26:158A.","journal-title":"Hepatology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-999-0084-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-999-0084-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-999-0084-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T09:29:06Z","timestamp":1587547746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-999-0084-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1007\/s11894-999-0084-5","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}